An evaluation of culture results during treatment for tuberculosis as surrogate endpoints for treatment failure and relapse.
It is widely acknowledged that new regimens are urgently needed for the treatment of tuberculosis.The primary endpoint in the Phase III trials is a composite outcome of failure at the end of treatment or relapse after stopping treatment.Such trials are usually both long and expensive.Valid surrogate endpoints measured during or at the end of treatm